Our findings on the physiological impact of decreased function of the brain OGDHC suggest that patients with different neurogenerative and psychiatric disorders, associated with decreased function of the brain OGDHC, may benefit from the OGDH upregulation, e.g., through administration of the physiological activator of OGDH, thiamine, or its pharmacological forms. Here, OGDH is linked to psychiatric disorder.